CDC anticipates shortage of TB screening test
The Centers for Disease Control and Prevention this week an anticipated shortage of Aplisol, one of two TB skin tests licensed by the Food and Drug Administration, which could begin this month and last three to 10 months. To alleviate the shortage, CDC recommends substituting the other skin test, Tubersol, for Aplisol and prioritizing high-risk groups for testing, among other actions. Monitor the status of the supply interruption .
Related News Articles
Headline
The Government Accountability Office yesterday released a report calling for the Department of Health and Human Services to improve its efforts responding to…
Headline
Despite elegant efforts to design for safe use, rigorous standards and regulatory requirements, and lots of training of health care professionals, there’s…
Headline
The Trump administration yesterday announced it issued executive orders authorizing 25% tariffs on all steel and aluminum imports. Importantly, both steel and…
Headline
The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such as continuous glucose monitors,…
Headline
The Department of Health and Human Services Sept. 30 released a statement on the dockworker strike at ports along the East and Gulf coasts, saying that…
Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…